Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Targeting specific cell interactions may help treat skin fibrosis.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Myrtus communis leaf extract may help with hair loss and wound healing.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.